{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Altretamine",
  "nciThesaurus": {
    "casRegistry": "645-05-6",
    "chebiId": "CHEBI:24564",
    "chemicalFormula": "C9H18N6",
    "definition": "A synthetic cytotoxic s-triazine derivative similar in structure to alkylating agent triethylenemelamin with antineoplastic activity.  Although the precise mechanism by which altretamine exerts its cytotoxic effect is unknown, N-demethylation of altretamine may produce reactive intermediates which covalently bind to DNA, resulting in DNA damage.",
    "fdaUniiCode": "Q8BIH59O7H",
    "identifier": "C544",
    "preferredName": "Altretamine",
    "semanticType": "Organic Chemical",
    "subclassOf": [
      "C292"
    ],
    "synonyms": [
      "2,4,6-Tris(dimethylamino)-s-triazine",
      "2,4,6-tris(dimethylamino)-s-triazine",
      "ALTRETAMINE",
      "Altretamine",
      "ENT 50852",
      "ENT-50852",
      "HMM",
      "HXM",
      "Hemel",
      "Hexalen",
      "Hexaloids",
      "Hexamethylamine",
      "Hexamethylmelamine",
      "Hexastat",
      "Hexinawas",
      "N,N,N',N',N\",N\"-hexamethyl-1,3,5-triazine-2,4,6-triamine",
      "N,n,n',N\"N\"-hexamethyl-1,3,5,-triazine-2,4,6,-triamine",
      "RB-1515",
      "WR-95704",
      "altretamine",
      "s-Triazine, 2,4,6-tris(dimethylamino)-"
    ]
  }
}